Experienced in Cholesteatoma

Pengsheng Chen

Xuzhou, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Cholesteatoma
Xuzhou, CN 
OverviewLocationsClinical Research

Overview

Pengsheng Chen practices in Xuzhou, China. Chen is rated as an Experienced expert by MediFind in the treatment of Cholesteatoma. Their top areas of expertise are Heart Attack and Cholesteatoma.

Their clinical research consists of co-authoring 14 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Cholesteatoma.

Locations

Xuzhou, 221000, China
Other Locations
Department Of Otolaryngology Head And Neck Surgery, Suzhou, 215003, China
Nanjing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction: a Multicenter Randomized Double-blind Placebo-controlled Trial (OPTIMA-6)
Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction: a Multicenter Randomized Double-blind Placebo-controlled Trial (OPTIMA-6)
Enrollment Status: Recruiting
Publish Date: October 28, 2024
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of an Early Phase Single Bolus r-SAK for Acute Myocardial Infarction: a Multi-center Randomized Clinical Trial (OPTIMA-5)
Efficacy and Safety of an Early Phase Single Bolus r-SAK for Acute Myocardial Infarction: a Multi-center Randomized Clinical Trial (OPTIMA-5)
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drug: Recombinant Staphylokinase
Study Phase: Phase 4
View 1 Less Clinical Trial

14 Total Publications

1-year outcomes of single bolus r-SAK before primary PCI for STEMI: The follow-up of OPTIMA-5.
1-year outcomes of single bolus r-SAK before primary PCI for STEMI: The follow-up of OPTIMA-5.
Journal: Journal of biomedical research
Published: May 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile